JP2009504761A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009504761A5 JP2009504761A5 JP2008527115A JP2008527115A JP2009504761A5 JP 2009504761 A5 JP2009504761 A5 JP 2009504761A5 JP 2008527115 A JP2008527115 A JP 2008527115A JP 2008527115 A JP2008527115 A JP 2008527115A JP 2009504761 A5 JP2009504761 A5 JP 2009504761A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- formula
- heteroaryl
- short
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC(C)*C(*=CC(C)(*=B1)[Al]*N(*)*)=C1* Chemical compound CC(C)*C(*=CC(C)(*=B1)[Al]*N(*)*)=C1* 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70965505P | 2005-08-19 | 2005-08-19 | |
| PCT/US2006/032027 WO2007024600A2 (en) | 2005-08-19 | 2006-08-16 | Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009504761A JP2009504761A (ja) | 2009-02-05 |
| JP2009504761A5 true JP2009504761A5 (https=) | 2009-09-24 |
Family
ID=37772166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008527115A Pending JP2009504761A (ja) | 2005-08-19 | 2006-08-16 | 睡眠剤と置換ビスアリール及びヘテロアリール化合物の組み合わせ物及び治療でのその使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7618650B2 (https=) |
| EP (1) | EP1928442B1 (https=) |
| JP (1) | JP2009504761A (https=) |
| KR (1) | KR20080038416A (https=) |
| CN (1) | CN101242819A (https=) |
| AR (1) | AR055609A1 (https=) |
| AT (1) | ATE447400T1 (https=) |
| AU (1) | AU2006283703A1 (https=) |
| BR (1) | BRPI0614943A2 (https=) |
| CA (1) | CA2617980A1 (https=) |
| DE (1) | DE602006010219D1 (https=) |
| ES (1) | ES2336142T3 (https=) |
| MX (1) | MX2008001778A (https=) |
| RU (1) | RU2008110498A (https=) |
| SG (1) | SG140147A1 (https=) |
| TW (1) | TW200815009A (https=) |
| WO (1) | WO2007024600A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2889811B1 (fr) * | 2005-08-19 | 2009-10-09 | Sanofi Aventis Sa | Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique. |
| US8231902B2 (en) * | 2005-11-18 | 2012-07-31 | Accu-Break Technologies, Inc. | Segmented pharmaceutical dosage forms |
| US8338367B2 (en) | 2008-10-15 | 2012-12-25 | Boehringer Ingelheim International Gmbh | Fused heteroaryl diamide compounds useful as MMP-13 inhibitors |
| US8785489B2 (en) | 2008-10-17 | 2014-07-22 | Boehringer Ingelheim International Gmbh | Heteroaryl substituted indole compounds useful as MMP-13 inhibitors |
| CN102018681A (zh) * | 2010-12-10 | 2011-04-20 | 荣港生技医药科技（北京）有限公司 | 一种美乐托宁缓释剂、其制备方法及其应用 |
| US20130060052A1 (en) * | 2011-01-17 | 2013-03-07 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
| US9120757B2 (en) | 2013-03-14 | 2015-09-01 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| PL2970132T3 (pl) | 2013-03-14 | 2021-04-06 | Epizyme, Inc. | Inhibitory metylotransferazy argininy i ich zastosowania |
| CN116715633B (zh) * | 2022-04-27 | 2025-08-12 | 杭州新元素药业股份有限公司 | 可用于降尿酸的化合物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001502675A (ja) * | 1996-10-21 | 2001-02-27 | ニューロサーチ・アクティーゼルスカブ | １―フエニル―ベンズイミダゾール化合物及びこれをｂａｇａ▲下ａ▼―レセプターモデュレーターとして使用する方法 |
| US20040258750A1 (en) * | 1999-06-28 | 2004-12-23 | Gerard Alaux | Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| CZ20023775A3 (cs) * | 2000-04-24 | 2003-10-15 | Teva Pharmaceutical Industries Ltd. | Zolpidem hemitartrát |
| GT200600042A (es) * | 2005-02-10 | 2006-09-27 | Aventis Pharma Inc | Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a |
-
2006
- 2006-08-16 KR KR1020087006619A patent/KR20080038416A/ko not_active Withdrawn
- 2006-08-16 BR BRPI0614943-0A patent/BRPI0614943A2/pt not_active IP Right Cessation
- 2006-08-16 AT AT06789813T patent/ATE447400T1/de not_active IP Right Cessation
- 2006-08-16 CA CA002617980A patent/CA2617980A1/en not_active Abandoned
- 2006-08-16 RU RU2008110498/04A patent/RU2008110498A/ru not_active Application Discontinuation
- 2006-08-16 EP EP06789813A patent/EP1928442B1/en active Active
- 2006-08-16 WO PCT/US2006/032027 patent/WO2007024600A2/en not_active Ceased
- 2006-08-16 ES ES06789813T patent/ES2336142T3/es active Active
- 2006-08-16 DE DE602006010219T patent/DE602006010219D1/de active Active
- 2006-08-16 JP JP2008527115A patent/JP2009504761A/ja active Pending
- 2006-08-16 MX MX2008001778A patent/MX2008001778A/es not_active Application Discontinuation
- 2006-08-16 SG SG200801326A patent/SG140147A1/en unknown
- 2006-08-16 AU AU2006283703A patent/AU2006283703A1/en not_active Abandoned
- 2006-08-16 CN CNA2006800296536A patent/CN101242819A/zh active Pending
- 2006-08-17 AR ARP060103594A patent/AR055609A1/es unknown
- 2006-08-18 TW TW095130323A patent/TW200815009A/zh unknown
-
2008
- 2008-02-06 US US12/027,022 patent/US7618650B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014219855B2 (en) | Trk-inhibiting compound | |
| JP6511430B2 (ja) | がんの治療のための化合物および組成物 | |
| BR112017016193B1 (pt) | Derivados de 4h-pirrolo[3,2-c]piridin-4-ona | |
| KR20070014184A (ko) | 성기능 장애 치료용 신규 약제학적 조성물 ⅱ | |
| JP2011509309A5 (https=) | ||
| EP1988898A2 (en) | Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin | |
| JP2003063994A (ja) | アルツハイマー病およびパーキンソン病に関連する痴呆または認識障害のための組合せ治療 | |
| SK15432002A3 (sk) | 2-acylindolové deriváty a ich použitie ako protinádorového prípravku | |
| CN105120868A (zh) | 组合治疗 | |
| US20050182089A1 (en) | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist | |
| JP2008511569A (ja) | 注意欠如活動過多障害の治療方法 | |
| US7618650B2 (en) | Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof | |
| RU2012130929A (ru) | Гетероциклические соединения в качестве ингибиторов янус-киназы | |
| JP2009504761A5 (https=) | ||
| EP1708706A1 (en) | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist | |
| JP2008543782A (ja) | ５−ｈｔ１ａ受容体のピペラジン−ピペリジンアンタゴニストおよびアゴニスト | |
| US8716292B2 (en) | Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity | |
| JP2008255064A (ja) | 睡眠障害予防治療剤 | |
| JP4555685B2 (ja) | 肥満およびｃｎｓ障害の処置のための選択的ｄ１／ｄ５レセプターアンタゴニスト | |
| CN1867333A (zh) | 含单胺神经递质再摄取抑制剂和乙酰胆碱酯酶抑制剂的药物组合物 | |
| KR20260022307A (ko) | Trek(twik 관련 k+ 채널) 채널 기능의 억제제 | |
| EP4326269A1 (en) | Compounds with improved cardiac safety for the treatment of cancer and neurodegenerative disorders | |
| EP4387973A1 (en) | Quinazoline-thiohydantoin fused heterocycles which are suitable for treating, ameliorating or preventing a proliferative disorder | |
| JP2006501244A5 (https=) | ||
| JP2009504760A (ja) | 催眠剤及びＲ（＋）−α−（２，３−ジメトキシ−フェニル）−１−［２−（４−フルオロフェニル）エチル］−４−ピペリジンメタノールの組み合わせ物並びに治療でのその使用 |